Capitalising on Australia’s semiconductor industry

Good morning,

In this edition of Archer’s Newsletter we highlight the Company’s first joint fabrication of graphene devices with an external foundry partner.

The joint fabrication involved a multi-project wafer (MPW) run with a foundry partner in Germany to validate one of Archer’s Biochip graphene device designs.

Archer’s Biochip graphene devices are now on their way towards foundry readiness, as they have advanced from design and into development stages.

The recent Biochip progress demonstrates how Archer fits into the semiconductor value chain through the fabless semiconductor model.

Archer’s Annual General Meeting is in Sydney next week, and I look forward to discussing with shareholders the Company’s activities and how we operate within the global semiconductor industry.

Sincerely,

Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX: AXE)

Click here to view the full Newsletter